Home
About
Info
Download
WebServices
Contact
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
(change energy unit to
kcal/mol
)
Found
3
hits in this display
Target
5-hydroxytryptamine receptor 3A
(Homo sapiens (Human))
Takeda Pharmaceutical
US Patent
Ligand
BDBM221524
(US9303045, 112 | US9303045, 8 | US9695195, 112)
Copy SMILES
Copy InChI
Affinity Data
IC50: 0.530nM
T: 2°C
Assay Description:
The 5HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux a...
More data for this Ligand-Target Pair
Target Info
PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
Ligand Info
PC cid
PC sid
In Depth
Details
US Patent
Copy BDB DOI
Target
5-hydroxytryptamine receptor 3A
(Homo sapiens (Human))
Takeda Pharmaceutical
US Patent
Ligand
BDBM221524
(US9303045, 112 | US9303045, 8 | US9695195, 112)
Copy SMILES
Copy InChI
Affinity Data
IC50: 0.530nM
T: 2°C
Assay Description:
The 5HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux a...
More data for this Ligand-Target Pair
Target Info
PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
Ligand Info
PC cid
PC sid
In Depth
Details
US Patent
Copy BDB DOI
Target
5-hydroxytryptamine receptor 3A
(Homo sapiens (Human))
Takeda Pharmaceutical
US Patent
Ligand
BDBM221524
(US9303045, 112 | US9303045, 8 | US9695195, 112)
Copy SMILES
Copy InChI
Affinity Data
IC50: 0.680nM
T: 2°C
Assay Description:
The 5HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux a...
More data for this Ligand-Target Pair
Target Info
PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
Ligand Info
PC cid
PC sid
In Depth
Details
US Patent
Copy BDB DOI